Alpine Global Management’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding NPCE
O
SCM
KLP
NCM
AC
Alpine Global Management's NPCE Position: Q3 2024 in Review
Alpine Global Management sold out of Neuropace (NPCE) in Q3 2024, closing a stake of 12,923 shares — an estimated $97.7K sold.
Alpine Global Management first reported a position in NPCE in Q2 2024 and held it in 1 quarter. The position peaked at $97.7K in Q2 2024. 48 funds tracked by Wall St. Rank hold NPCE as of Q3 2024.
- Alpine Global Management reported no remaining Neuropace position as of Q3 2024 after selling out during the quarter.
- Alpine Global Management sold 12,923 Neuropace shares in Q3 2024, an estimated $97.7K.
- Alpine Global Management first reported a position in Neuropace in Q2 2024 and held it in 1 quarter.
- Alpine Global Management's Neuropace position peaked at $97.7K in Q2 2024.
- 48 funds tracked by Wall St. Rank held Neuropace as of Q3 2024.
Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.